Grass pollen allergy

Efficacy of Sublingual Immunotherapy in Grass Pollen Allergy... 

Sublingual immunotherapy SLIT Grass pollen allergy... 

Fokkens, W.J., Vroom, T.M., Rijntjes, E. and Mulder, P.G. (1989), Fluctuation of the number of CD-l(T6)-positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with an isolated grass-pollen allergy before, during, and after the grass-pollen season. J. Allergy Clin. Immunol. 84, 39-43. 

Miller, A. C. M. L., and Tees, E. C., A metabolizable adjuvant Clinical trial of grass pollen-tyrosine adsorbate, Clin. Allergy. 4, 49-55, 1974. 

Francis JN, Till SJ, Durham SR Induction of 1L-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003 111 1255-1261. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C. Wrzyszcz M, Blaser K, Akdis CA lL-10 and TGF-P cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003 33 1205-1214. 

Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005 116 608-613. 

Francis JN. Till SJ, Durham SR Induction ofIL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003 111 1255-1261. 

Walker SM, Varney VA, Gaga M, Jacobson MR, Durham SR Grass pollen immunotherapy efficacy and safety during a 4-year follow-up study. Allergy 1995 50 405-413. 

Roder E, Berger MY, Hop WC, Bernsen RM, de Groot H, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 2007 119(4) 892-8. [Epub 2007 Feb 23]. 

Clavel R, Andre C, Bousquet J Reduction of corticosteroid therapy by sublingual immunotherapy. Double blind study against placebo of standardised 5 grass pollen extract in rhinitis. Allergy 1995 50/26 279. 

Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S, Andre C Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999 54 819-828. 

Fanta C, Bohle B, Hirt W, Siemann U, Horak F, Kraft D, Ebner H, Ebner C Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999 120 218-224. 

Clavel R, Bousquet J, Andre C Clinical efficacy of sublingual-swallow immunotherapy A double-blind, placebo-controlled trial of standardized five-grass-pollen extract in rhinitis. Allergy... 

Dolz I, Martinez-Cocera C, Bartolome J A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy 1996 51 489-500. 

Marcucci F, Sensi L, Frati F, Senna GE, Canonica GW, Parmiani S, Passalacqua G Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT) Safety and immunologic implications. Allergy 2001 56 1091-1095. 

Quirino T, Iemoli E, Siciliani S, Parmiani S, Milazzo F Sublingual versus injective immunotherapy in grass pollen allergic patients A double blind (double dummy) study. Clin Exp Allergy 1996 26 1253-1261. 

Hufhagl K, Winkler B, Focke M, Baier K, Valenta R, Kraft D, Wiedermann U Induction of mucosal tolerance by coapplication of recombinant Bet v 1, the major birch pollen allergen, recombinant Phi p 1 and Phi p 5, major grass pollen allergens, in polysensitized mice. Allergy 2002 57(suppl 73) 49. 

Sabbah A, Hassoun S, Le Sellin J, Andre C, Sicard H A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994 49 309-313. 

Caffarelli C Preseasonal local allergoid immunotherapy to grass pollen in children A doubleblind, placebo-controlled randomized trial. Allergy 2000 55 1-6. 

---